Fusion proteins for HBV (Nventa)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameFusion proteins for HBV (Nventa)

Drug Alias NameHsp fusion (Nventa)Hsp fusion (Stressgen)Fusion proteins for HBV (Stressgen)hepatitis B virus vaccine (Nventa)vaccine, Hsp-HBV antigen fusion protein (StressGen) +[8]

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Application > Therapeutic vaccine

Mechanisms of ActionHeat-shock protein stimulants

TargetsHeat-shock protein

Therapy Area/IndicationsHepatitis B

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNventa Biopharmaceuticals Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNventa Biopharmaceuticals Corp

Active IndicationsN/A

Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A